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This review discusses sedation for regional anaesthesia in the adult population. The first
section deals with general aspects of sedation and shows that the majority of patients receiving
sedation for regional anaesthesia are satisfied and would choose it again. Methods of assessing
the level of sedation are discussed with emphasis on clinical measures. The pharmacology of
the drugs involved in sedation is discussed, with propofol and remifentanil appearing to be the
combination of choice for sedation in regional anaesthesia. The techniques for administering
sedation are discussed and replacement of the traditional repeated boluses or continuous infu-
sion with pharmacokinetic and patient-controlled systems is supported. Patient satisfaction
studies suggest that patient-controlled systems are preferred.
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Regional anaesthesia is popular and offers several benefits
to the patient. The top three from the patient’s point of
view are staying awake, early family contact, and early
food intake.21 This shows that patients are interested in
postoperative landmarks4 62 and their importance regarding
patient satisfaction. For the anaesthetist, cardiovascular
and respiratory stability, rapid postoperative recovery,4 and
preservation of protective airway reflexes are the most
important advantages of regional anaesthesia. Some draw-
backs are linked with regional anaesthesia techniques: pain
at the puncture site,62 fear of needles,30 and recall of the
procedure.63 These factors stress the importance of seda-
tion that offers analgesia, anxiolysis, and amnesia.
Sedation can be described as a continuum ranging from
minimal sedation, such as anxiolysis, through to general
anaesthesia.2 In contrast to general anaesthesia, verbal
contact is usually maintained or is possible when needed.
The term ‘conscious sedation’ is used for sedation for thera-
peutic or diagnostic procedures, and ‘monitored anaesthesia
care’ for sedation to supplement local or regional anaesthe-
sia. Unfortunately, these terms are not consistently applied.
Sedation is part of the general management of a patient
receiving a regional block and being awake during the whole
surgical procedure. The aims include general patient
comfort, freedom from specific discomfort, and some
amnesia for both the block procedure and the surgical oper-
ation, in order to meet the patient’s preference and safety.
Sedation has been shown to increase patient satisfaction
during regional anaesthesia114 and may be considered as a
means to increase the patient’s acceptance of regional
anaesthetic techniques. For surgery under regional anaesthe-
sia, sedation is a valuable tool to make it more convenient
for the patient, the anaesthetist, and the surgeon. This review
focuses on sedation in regional anaesthesia in adult patients,
including patient preference and satisfaction, current pharma-
cological research, and techniques of sedation.
General aspects
Patient satisfaction is important when dealing with inter-
ventions like pain management or sedation. It is usually
assessed by a verbal rating scale from 0¼completely dissa-
tisfied to 10¼completely satisfied. This is a subjective
measure reflecting the ratio between expectation and
occurrence of events. Patient satisfaction with sedation has
been investigated widely and is generally very high.104 114
In contrast, less is available on patient’s preference.
A recent study found that 13 of 98 (12%) patients with an
upper limb block without sedation for hand surgery would
like to be sedated for future similar surgery,55 whereas in
another study more than 90% of 169 patients receiving
propofol or midazolam–fentanyl sedation for cosmetic
surgery would opt for sedation rather than general anaes-
thesia for future surgery.40 This may suggest that patients
are generally satisfied with what they are offered, but satis-
faction per se is a complex and multifactorial feeling and
standard questionnaires may not take this into account.56
There are different indications for sedation or analgesia/
sedation in the context of regional anaesthesia. First, an
initial bolus or continuous infusion provides anxiolysis, as
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around 50% of patients are anxious before receiving a
regional block.104 It is helpful to have a calm and coopera-
tive patient during placement of the block and decreases
from the response to needle puncture or electric stimu-
lation. Additionally, sedation reduces usually postoperative
recall, which is important for many patients,63 but can be
undesirable. The global tolerance of a regional block has
been shown to be better with sedation than without.54
Moreover, continuous sedation will help to increase
comfort, especially during long surgery or uncomfortable
positioning. This may increase the acceptance of regional
anaesthesia. Around 5–10% of regional blocks are insuffi-
cient.113 There are no controlled studies of sedation as a
means of supplementing an incomplete block, but general
anaesthesia is needed if an additional block or opioids do
not improve analgesia.
Sedatives can help to decrease the requirement of
opioid analgesics which contributes to the reduction of
postoperative nausea and vomiting.6 80 Finally, it has been
shown that sedation allows the choice of a shorter anaes-
thetic method (e.g. local or regional anaesthesia vs spinal
or general anaesthesia), which improves time to recovery
and discharge.81 84 113
Sedation does involve some risks, especially induction of
respiratory depression,94 haemodynamic instability,69 or
uncontrolled movements.66 The reported incidence of
adverse effects is variable (Table 1) as different definitions
of ‘events’ and different dosages and combinations of drugs
are used. In a large study of 17 000 patients undergoing cat-
aract surgery, the incidence of adverse effects, predomi-
nantly cardiovascular events, was significantly higher when
i.v. sedatives were used compared with no sedation.1 51
Table 1 Side-effects and complications associated with sedation during regional anaesthesia
Number
of
patients
ASA Type of
surgery and
anaesthesia
Sedative
drugs
Minor adverse
effects
(desaturation,
haemodynamic
instability)
Severe adverse
events
Comment Reference
56 — Plexus spinal/
epidural
anaesthesia
Midazolam
titrated to
OAA/S 3
Excitement or
disinhibition: 2
(3.6%), apnoea:
4 (7.1%)
— Some patients
received
additional
fentanyl due to
pain
64
35 I–
III
Plexus or spinal
anaesthesia
Propofol 0.1
mg kg21
min21
Hypotension: 3
(9%),
bradycardia: 2
(2%)
69
60 Gynaecological
surgery spinal
anaesthesia
Propofol
titrated to
OAA/S 3 or
4
Apnoea: 17
(28.3%)
Airway
obstruction: 9
(15%)
75
63/62 I or
II
Plexus or spinal
anaesthesia
Propofol/
remifentanil
Systolic arterial
pressure ,90
mm Hg: 1
(1.5%) / 7
(11.3%)
— Drugs titrated
down as
haemodynamic
instability
begins
95
72 I–
III
Plexus or spinal
anaesthesia
Remifentanil
0.2 mg kg21
min21
Hypotension: 1
(1%),
bradycardia: 1
(1%)
- Authors
considered
remifentanil
dose as too
high
69
15 I or
II
Eye surgery,
retrobulbar
block
Remifentanil
0.03 mg
kg21min21,
propofol
titrated to
OAA/S 3
No hypotension
or desaturation
,96%
— 44
20/20 I or
II
Eye surgery,
retrobulbar
block
Remifentanil
0.5 mg kg21
or 1 mg kg21,
propofol 0.5
mg kg21
Desaturation
,90%, or
ventilatory
frequency ,6
bpm, or apnoea
.20 s: 1 (5%)/
12 (60%)
— — 85
117 — Plexus spinal/
epidural
anaesthesia
Sevoflurane
titrated to
OAA/S 3
Excitement or
disinhibition: 35
(30%),
bradycardia: 1
(0.9%), apnoea:
6 (5.1%)
Laryngospasm:
1 (0.9%)
Some patients
received
additional
fentanyl due to
pain
46
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Severe airway obstruction during arthroscopic shoulder
surgery performed under interscalene block and sedation13
78 showed that, on the one hand, a lightly sedated patient
was able to complain of discomfort whereas in a deeply
sedated patient the recognition of severe airway obstruc-
tion can be delayed. However, increasing level of con-
sciousness raises the incidence of postoperative recall97
and the patient may be more agitated.
Patient factors
The dose requirements for sedative agents are decreased in
elderly patients.64 90 The risk of desaturation or haemo-
dynamic instability is increased in patients .70 yr com-
pared with younger patients.41 Similar findings occurred in
patients classified ASA III/IV or ASA I/II, but no gender
differences were found.42 Previously undiagnosed obstruc-
tive sleep apnoea was frequently observed in sedated
patients.96
Elderly people are expected to be less anxious,7 40 poss-
ibly because of their more extended anaesthetic experi-
ence. This suggests that the indications for sedation should
be more restricted in the elderly population because of the
increased risk of haemodynamic complications and the
lower need for sedation. The influence of gender on
anxiety is unclear with several studies finding that females
are more anxious than males7 40 and others not.10 Further
studies are needed to establish the influence of gender on
sedation requirements.
Assessing the level of sedation
The modified Wilson scale (Table 2), a variant of the
Ramsey83 and Wilson111 scales, has an inter-rater agree-
ment of 84%76 and is quick and simple to use in clinical
practice. The observer’s assessment of alertness/sedation
(OAA/S) (Table 3), however, has an inter-rater agreement
that varies between 85% and 96% depending on the level
of sedation.17 Although it has more items than other
scales, it may be the best choice if precise assessment of
sedation is required.
The visual analogue scale (VAS) can be used as a
patient-based self-monitoring of sedation. A good overall
correlation between patient and blinded observer scores
was shown,97 but there may be wide variation between the
patients.82 The VAS is only applicable within light seda-
tion levels. Observer-based VAS shows an inter-rater
agreement that varies from 76% for deep sedation to 90%
for light sedation.17 Staff-based VAS is a quick, simple,
and accurate tool for clinical use.
The use of BIS for monitoring conscious sedation is a
topical subject. BIS has been reported to accurately predict
loss of consciousness in several studies34 52 101 dealing
with general anaesthesia. With deeply sedated patients
(OAA/S 2–3), a good correlation between the OAA/S and
BIS was found using propofol61 or a combination of fenta-
nyl, midazolam, and propofol.89 However, BIS is limited
in its abilities to discriminate between different levels of
light sedation,47 72 82 although new technology seems to be
better at filtering out EMG artifacts.
The effect on BIS of adding remifentanil to propofol
sedation has been investigated in two studies,99 101 one of
which demonstrated a dose-related decrease in BIS.99
Ketamine produced higher BIS levels than expected in
one study,67 but another study showed no influence.72 A
recent report described three cases of combined propofol–
midazolam sedation where patients were only lightly
sedated, but the BIS-index decreased to levels between 40
and 50 (range 0–100,,60 normally equates to unconscious-
ness) shortly after the start of the midazolam infusion.105
In addition, the large inter-individual pharmacodynamic
variability of sedative drugs did not allow a reliable scale to
assess sedation with the use of BIS.
In deep sedation, BIS seems to be a useful tool for
monitoring the level of sedation. However, with light seda-
tion, for example, in a regional anaesthesia setting, BIS
does not seem to be reliable. The combination of drugs
further complicates the interpretation of the data gained
due to the different pharmacokinetic and pharmacody-
namic properties of each drug.
Studies with volunteers and clinical studies of patients
with regional anaesthesia have evaluated auditory
evoked potentials (AEP). It has been shown that mid-
latency-AEP-index correlates well with sedation level and
Table 3 Observer’s assessment of alertness/sedation
Score Sedation
level
Responsiveness Speech Facial
expression
Eyes
5 Alert Responds
readily to name
Normal Normal Clear,
no
ptosis
4 Light Lethargic
response to
name
Mild slowing Mild
relaxation
Glazed
or mild
ptosis
3 Moderate Response only
after name is
called loudly
Slurring or
prominet
slowing
Marked
relaxation
Glazed
and
marked
ptosis
2 Deep Responds only
after mild
prodding or
shaking
Few
recognizable
words
— —
1 Deep sleep,
unconscious
Does not
respond to mild
prodding or
shaking
— — —
Table 2 Modified Wilson sedation scale
Score Description
1 Oriented, eyes may be closed but can respond to ‘Can you tell
me your name?’ ‘Can you tell me where you are right now?’
2 Drowsy; eyes may be closed, arousable only to command:
‘(name), please open your eyes’.
3 Arousable to mild physical stimulation (earlobe tug)
4 Unarousable to mild physical stimulation
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is, in contrast to BIS, able to discriminate between all
OAA/S-levels in patients sedated with propofol or midazo-
lam.31 A good correlation of late-latency-AEP with seda-
tion level has been shown in patients sedated with
propofol or propofol and remifentanil but not with remi-
fentanil.38 Until guidelines for its clinical use can be
established, AEP as a measure of sedation levels is not
ready for routine clinical practice.
Factors influencing the level of sedation
Several studies have shown that spinal32 82 and epidural22
103 anaesthesia can reduce anaesthetic requirements and
induce sedation. A positive correlation between the depth
of sedation and the extent of the block has been shown,22
24 32 and sedation to be dose related for epidural anaesthe-
sia with procaine, as assessed by VAS, BIS, and brain
steam evoked potentials.22 The peak sedation effect is
usually detected 30–45 min after starting the block. The
hypothesis explaining this effect is a decrease in afferent
sensory input with consecutive inhibition of the
reticulo-thalamo-cortical mechanisms. Systemic levels of
lidocaine48 or bupivacaine103 do not seem to explain seda-
tion. A second peak of sedation was seen in one study,
with delayed rostral spread of anaesthetic proposed as a
mechanism.82 This second peak was not detected in other
studies.57
The sedative effect can be enhanced by the addition of
adrenaline.115 Two mechanisms are suggested: augmenta-
tion of the local concentration of the anaesthetic through
vasoconstriction and direct stimulation of central a2-
adrenoceptors by rostral spread of adrenaline. However,
this mechanism is still unproven.
Listening to music is known to relax patients under-
going regional anaesthesia and has been shown to reduce
the consumption of sedatives116 and to decrease periopera-
tive pain scores,68 but not have any anxiolytic effect.68
Patients’ satisfaction was significantly higher when listen-
ing to music116 and almost all the patients would choose
music again in future for similar surgery.68
In the setting of regional anaesthesia, hypnosis has been
used26 to provide light sedation and amnesia. However,
success of this technique was limited by the need of sup-
plementary analgesics.93 As the patient needs to relax and
concentrate for the induction of hypnosis, most attempts
for emergency operations failed and in elective cases for
more than 1 h.93 In the hands of an experienced specialist,
hypnosis may be useful in suitable patients, and when
sedatives are contraindiced.
Ideal pharmacokinetic and pharmacodynamic
properties of a sedative agent
The ideal pharmacokinetic properties of sedative agents
include a rapid onset, easy titration, and high clearance.
Pharmacodynamic factors are dependent on actions within
the effect-site compartment, which is described by the
constant keo expressing the time required for the blood and
effect-site concentrations to equilibrate.60 100 This constant
varies for sedative agents and with the pharmacokinetic
model used.65 92 The time to peak effect (TPE) after bolus
injection seems to be a better measure than keo for com-
paring drugs70 as it is independent of the pharmacokinetic
model used and the time-course of drug effect is more
predictable.
100 Blood concentration, however, especially
during non-steady-state, is a poor indicator of drug
effect,97 with calculated concentration in the effect com-
partment providing better results.109
Elimination half-life is of limited use in a multicompart-
ment model.92 Therefore, the context-sensitive half-time45
has been introduced, defined as ‘the time required for the
plasma drug concentration to decline 50% after terminat-
ing the infusion . . . where context refers to infusion dur-
ation’. A short context-sensitive half-time and a high
clearance are essential for rapid offset of sedation and fast
recovery.
The ideal sedative agent should also have minimal side-
effects, particularly a lack of haemodynamic impairment,
respiratory depression, and thermoregulatory interference
which may already be caused by a spinal block. Amnesic
properties of a sedative agent may be useful during place-
ment of a nerve block or if the patient has to remain in an
awkward position for a long time during surgery. The
patient may or may not view amnesia as an advantage and
may prefer memory of the operation.
Premedication for sedation
Midazolam has suitable properties for premedication as it
is anxiolytic,102 provides good amnesia,74 102 decreases
propofol requirements,74 but does not prolong the stay at
the recovery room.102 Recently, clonidine, which has good
anxiolytic and sedative properties, has been used,107 and
several studies have found that oral clonidine decreases
propofol consumption28 37 75 and can lower the incidence
of propofol-induced uncontrolled movements.75 In contrast
to midazolam, clonidine does not produce amnesia at the
low dosages used for sedation.75
Propofol
A dose-related sedative effect has been demonstrated,16 97
and non-dose-related anxiolysis as well.97 Amnesia is pro-
portional to the administered dose97 104 but is incomplete
and less effective than with midazolam.44 The analgesic
properties of propofol are known to be poor.95 One of the
main advantages of propofol is its pharmacokinetic profile,
which leads to fast induction,91 easy alteration of the seda-
tion level,87 and quick recovery.111 Haemodynamic
impairment, defined as decrease in arterial pressure and
increased incidence of bradycardia is reported at infusion
rates of 100–200 mg h21 69 and is similar if a spinal or
Sedation and regional anaesthesia
11
axillary block is used.59 Haemodynamic stability was
shown to be improved by adding low-dose ketamine.29
The ventilatory response is reported to be reduced.12 77
The incidence of nausea and vomiting after propofol infu-
sion is generally low, and an antiemetic effect has been
suggested.14 97 Propofol is the nearest to an ideal agent for
sedation during regional anaesthesia, because of its favou-
rable pharmacokinetic profile, with rapid onset and offset.
Benzodiazepines
Of the currently available benzodiazepines, midazolam is
the drug preferred for sedation due to its reasonably rapid
on- and off-set time. It produces good sedation,20 88 and
excellent amnesia,20 110 111 112 but depresses respiration
and arterial pressure and has no specific analgesic proper-
ties.20 When compared with propofol, the offset is signifi-
cantly slower with midazolam.110 111 Interestingly, it has
been shown that midazolam causes significantly less seda-
tion in patients with naturally red hair compared with
others,18 a change in the melanocortine system is postu-
lated as part of the mechanism. Cases of paradoxical reac-
tion have been reported,66 with advanced age proposed as
a predisposing factor.66 106 The availability of flumazenil
as specific antagonist58 is an additional safety factor,
although its elimination is faster than that of midazolam.
A majority of patients who had midazolam or propofol
sedation for similar oral surgery on different occasions
preferred midazolam to propofol,87 but no comparable
data are available from a regional anaesthesia setting.
Clonidine and dexmedetomidine
Clonidine and dexmedetomidine are a2-adrenoreceptor
agonists with anxiolytic and dose-related sedative proper-
ties. Clonidine provides good analgesia at high dosages (5
mg kg21 orally or 4 mg kg21 h21 i.v.) without a depressant
effect on respiration or inducing nausea or vomiting.36 39
Significant anterograde amnesia was reported at high
doses,39 whereas retrograde amnesia is unusual.39 75 The
effect of clonidine on haemodynamic variables is contro-
versial, with some authors suggesting no haemodynamic
impairment in young and healthy patients,39 whereas
others reported decreased arterial pressure9 107 and brady-
cardia.27 87 A dosage of 1.5 mg kg21 h21 was found to be
clinically effective without significant haemodynamic
impairment.27 The distribution half-life of 1.2 h and an
elimination half-life of 14.6 h indicate a slow on- and
offset,25 an important drawback necessitating adminis-
tration well before surgery9 and a possible delay in dis-
charge after operation.
Both drugs interfere with thermoregulatory processes
and decrease postoperative shivering.19
Dexmedetomidine provides dose-related sedation and
prolongation of sensory block but causes significant
haemodynamic impairment19 and nausea and vomiting.11
The pharmacokinetic profile with an elimination half-life
of 2 h11 indicates a fast offset which is the major advan-
tage over clonidine, although neither of them has found its
way into routine use for sedation in regional anaesthesia.
Ketamine
Low-dose ketamine was reported to provide weak seda-
tion29 but excellent analgesia.8 It did not reduce propofol
requirements,29 but the addition of ketamine has a positive
effect on haemodynamic stability and can counteract the
propofol-induced respiratory depression29 due to its sym-
pathomimetic properties and central nervous system
effects.14 However, ketamine-induced dose-related nausea
and vomiting and the offset of pharmacodynamic effect
were prolonged at high dosages.8 29 Bad dreams or halluci-
nations were not reported at sedative doses.
Sevoflurane
Sevoflurane produced good, dose-related sedation and had
a faster recovery from sedation than midazolam.46 It
resulted in high patient acceptance and satisfaction, but
was associated with patient excitement and with theatre
pollution, which remains only within safety limits (,10
ppm) if a proper inhalation mask was used and the theatre
was sufficiently ventilated.43 The risks of pollution and
patient excitement33 46 47 make sevoflurane a ‘second
choice’ for sedation. The large inter-individual pharmaco-
dynamic of sevoflurane warrants slow titration to avoid
severe respiratory depression.
Opioids
Among the opioids, remifentanil is a potent analgesic59 69
95 with an excellent pharmacokinetic profile including a
TPE of 1.5 min, pharmacodynamic offset of 5.8 (SD 1.8)
min, short elimination half-life, and a time-independent
context-sensitive half-time.35 50 This is in contrast to alfen-
tanil, sufentanil, and fentanyl which have longer context-
sensitive half-times.23 50 Respiratory depression has been
reported to occur after single-use of remifentanil in a
dose-related fashion above 0.2 mg kg21 min21 or with 0.1
mg kg21 min21 in combination with propofol.71 Nausea
and vomiting is frequent59 95 as is pruritus.5 69 Muscular
rigidity is rare at usual dosages69 but frequent at higher
doses (.1 mg kg21 min21).23 Haemodynamic instability
is rarely seen at the dosage used for conscious sedation.95
In a meta-analysis of nine clinical trials, an infusion rate
for remifentanil of 0.1 mg kg21 min21 has been suggested
as an optimal balance between side-effects and sedative
effect.94 Anxiolysis and amnesia are less effective than
with propofol.69 95
Remifentanil has a definite5 but poor59 95 sedative
effect. It produces more side-effects at comparable
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sedative levels, especially respiratory depression.95 It has
been suggested that sedation is a ‘side effect’ of opioids5
which act as adjuncts to sedative agents to provide better
analgesia. This may be of interest for use during place-
ment of blocks. This leads to the possible combined use of
remifentanil and propofol, where, after block placement,
the remifentanil infusion rate is decreased, as has been
used in ophthalmology.85 Further studies in regional
anaesthesia are required to evaluate the optimal regime.
Techniques of sedation
Single or repeated bolus technique leads to an unstable
blood and effect-site concentration profile with the conse-
quence of adverse effects due to peak concentrations and
variability of sedation level and haemodynamic instabil-
ity.66 A continuous infusion with initial bolus leads to
rising blood concentrations over time,53 97 requiring
repeated adjustment of the infusion rate to maintain a
defined sedation level, which has to be considered
especially for prolonged surgery. This problem is over-
come by target-controlled infusion (TCI) where the admini-
stration is driven by microprocessor-controlled algorithms
based on pharmacokinetic models.108 The concentration of
the sedative agent at the effect site is stabilized more
quickly and can be maintained over time,53 and the level
of sedation can be changed and a new steady state reached
easily.16 53
Older and widely used algorithms use blood concen-
tration as the target, with good results.16 98 Newer algori-
thms target the effect-site concentration, leading into a
faster onset and better prediction of drug effect,100 and are
the subject of ongoing research.70 100 In our experience, an
effect-site concentration of propofol of 0.4–0.8 mg ml21
and 0.5–1.0 ng ml21 for remifentanil produces a satisfac-
tory level of sedation in most cases. However, slow titra-
tion is mandatory to cope with the inter-individual
pharmacodynamic effect of each drug.
Advanced concepts and trends: patient-controlled
sedation and patient-maintained sedation
In patient-controlled sedation (PCS), the patient has a
button which is linked to the pump which gives a bolus of
a sedative drug and allows the patient to titrate the seda-
tion according to their need. To avoid oversedation, most
PCS protocols have a lock-out period of 1–3 min. Both
propofol and midazolam have been used in this setting,
but propofol offers less postoperative amnesia, faster onset
of pharmacodynamic effect, and higher patient prefer-
ence.88 An initial bolus can be used to speed up induction,
but as with any bolus-based concept, PCS may produce
unwanted peak effects49 and an unstable sedation profile.
This could be avoided using a basal infusion giving the
patient the option to have some boluses. The total con-
sumption of propofol has been reported to be significantly
less with PCS compared with other regimens15 and overse-
dation is rare if a suitable lock-out time is used.86 There is
no reported increase in adverse effects in studies compar-
ing PCS with TCI or continuous infusion.15 Patients’ satis-
faction is significantly higher with PCS sedation than with
anaesthetist-administered sedation.79 Patients who had a
device provided but did not use it were more satisfied than
patients without any sedation.87 A majority of patients
who had PCS or conventional sedation for two similar
operations preferred self-administered sedation.79
In patient-maintained sedation (PMS), a TCI system is
equipped with a demand button giving patients the option
to increase the target concentration to their needs,49 a vari-
able lock-out period is defined to avoid excessive overse-
dation, but both inadequate sedation and oversedation49 73
have been reported. One of the main problems is the slow
onset of sedation, but a recent protocol was able to improve
this with initial bolus and implementation of effect-site
target TCI algorithms.3 A recent study comparing PCS and
PMS in patients undergoing surgical extraction of third
molar teeth found a strong preference for PMS.86
Patients’ satisfaction clearly demonstrates that many of
them are willing to be involved in their own treatment.
Unfortunately, there are no studies of regional or spinal
anaesthesia using PCS, with studies coming mainly from
dental surgery or endoscopy.
PMS is still experimental and the optimal regimen has
not yet been found. Patients’ preference strongly rec-
ommends further research. It offers the unique combi-
nation of the advantages of both effect-site targeting and
involving the patient into the procedure titrating the seda-
tive effect on his needs.
Conclusion
The increased use of regional anaesthesia in recent years
has led to an increased need for sedation during surgery in
awake patients. Sedation is known to increase patient’s
acceptance of regional anaesthesia and to greatly improve
patient wellbeing during the surgical procedure. A better
knowledge of the pharmacodynamic and pharmacokinetic
properties of sedative drugs has made the use of sedation
safer and more effective. The development of new modes
of administration is ongoing and has improved the quality
of sedation.
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